Owned by the Association for International Promotion & Study in Tumors (APSIT)
From glioma gloom to immune bloom: unveiling novel immunotherapeutic paradigms-a review
In tumor therapeutics, the transition from conventional cytotoxic drugs to targeted molecular therapies, such as those targeting receptor tyrosine kinases, has been pivotal. Despite this progress, the clinical...